Compare Mesoblast Limited (MESO) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Impinj Inc — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Impinj Inc trades at $137.09 (market cap $4.19B). The key difference: Impinj Inc is the larger of the two by market cap, and Mesoblast Limited is trading nearer its 52-week high, Impinj Inc nearer its low. Which is the better fit depends on your goals.
| MESO | PI | |
|---|---|---|
Market Cap | $2.17B | $4.19B |
Sector | Technology | Technology |
52-Week High | $20.96 | $241.91 |
52-Week Low | $12.88 | $91.34 |
Enterprise Value | $2.17B | $4.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
